Y-mAbs Therapeutics (YMAB) PT Lowered to $67 at Wedbush, Following Earnings

February 26, 2021 3:34 PM EST
Get Alerts YMAB Hot Sheet
Price: $32.56 -2.81%

Rating Summary:
    10 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 8
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Wedbush analyst David Nierengarten lowered the price target on Y-mAbs Therapeutics (NASDAQ: YMAB) to $67.00 (from $71.00) while maintaining a Outperform rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change

Related Entities

Earnings